SlipstreamJobs tracks this role from the company's public career site. Apply directly on the employer's site.
Arlo is rebuilding health insurance for small businesses by redirecting premium dollars toward actual care rather than administrative overhead, fraud, and middlemen. The company operates at meaningful scale—profitable with hundreds of millions in premiums and tens of thousands of members—and is backed by top-tier VCs including Upfront Ventures, 8VC, and General Catalyst.
As VP of Clinical Strategy & Population Health, you will design the clinical foundation of Arlo's health plans, working across product, actuarial, and operations to define population health strategies, develop provider partnerships, and build models that deliver better outcomes at lower costs.
Key responsibilities include: shaping plan structures that drive preventive care and reduce wasteful spend; identifying key needs across member populations and developing scalable, data-driven programs; designing care navigation models for concierge and support services; identifying condition-focused opportunities (diabetes, MSK, oncology) and deciding whether to build in-house or partner; exploring integrated care delivery models that deepen patient-provider relationships; building relationships with value-based providers and health systems; and serving as the clinical expert in product, claims, and underwriting discussions.
You will have a clinical background (MD, DO, RN, NP, or MPH) with direct patient or health system experience. You've developed or led population health programs or value-based care models in a health plan, provider group, or ACO. You understand how health plan structures impact member behavior and provider incentives. You communicate effectively across clinical and business contexts, work comfortably with claims data, and thrive in ambiguous, early-stage environments. Startup experience or curiosity is valued.
The role offers high ownership from day one, direct impact on how people access care at scale, rapid career growth as the company expands, and the opportunity to apply AI to meaningful healthcare problems rather than extractive use cases.
